Cholera refer apurba sastry

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Loading Image
I now have all the information needed. Here is a comprehensive answer on Cholera in the style of Apurba Sastry's microbiology approach, compiled from the best available medical microbiology textbooks in the library:

CHOLERA

(As covered in medical microbiology - Apurba Sastry style)

Causative Organism

Vibrio cholerae - the causative agent of cholera.
  • Curved, Gram-negative rods (comma-shaped)
  • Highly motile with a single polar flagellum
  • Non-spore-forming, oxidase-positive
  • Fermentative, facultative anaerobe
  • Requires salt for growth
  • Grows best under alkaline conditions (pH 8.0-9.5) - inhibits many other Gram-negative bacteria

Classification / Serotyping

FeatureDetails
Serogroups>200 O-antigen serogroups
Epidemic serogroupsO1 and O139 (only these two cause cholera)
Serotypes of O1Inaba, Ogawa, Hikojima
Biotypes of O1Classical and El Tor
O139Resembles El Tor but also produces a polysaccharide capsule
Key point: Only O1 and O139 cause epidemic cholera. Other serogroups may cause sporadic diarrhea but not cholera.
  • V. cholerae El Tor (biotype) is responsible for the current 7th pandemic
  • O139 strains were first identified in 1992 in Bangladesh/India

Virulence Factors

1. Cholera Toxin (CT) - The Main Virulence Factor

CT is the most important virulence determinant. It is an A-B type toxin (ADP-ribosylating exotoxin).
Structure:
  • 5 B subunits (binding) - bind to GM1 ganglioside receptor on enterocyte surface
  • A subunit (active) - composed of A1 and A2 linked by a disulfide bond
Mechanism of Action:
Cholera Toxin Mechanism of Action
Step-by-step:
  1. B subunits bind to GM1 ganglioside receptor on the intestinal epithelial cell membrane
  2. A1 subunit is released (disulfide bond reduction) and translocated into the cell
  3. A1 catalyzes ADP-ribosylation (ADPR) of Gsα protein (stimulatory G-protein)
  4. ADP-ribosylated Gsα cannot dissociate from adenylate cyclase - locks it in permanently active state
  5. Persistent activation of adenylate cyclase → massive cAMP accumulation
  6. Elevated cAMP → hypersecretion of Cl⁻, K⁺, HCO₃⁻, Na⁺, and water into intestinal lumen
  7. Result: profuse watery diarrhea (no mucosal damage, no invasion)
Mnemonic: Binds GM1 → A1 ADPR Gsα → Cyclic AMP ↑ → Diarrhea

2. Toxin-Coregulated Pilus (TCP)

  • Long filamentous pili forming bundles on bacterial surface
  • Essential for colonization of the intestinal mucosa
  • Expression is co-regulated with cholera toxin (hence the name)
  • Belongs to the same pili family as gonococci

3. Biofilm Formation

  • In aquatic environments, V. cholerae forms polysaccharide biofilms
  • Mediate cell-cell adhesion and surface attachment
  • Important for survival in the environment

Epidemiology

  • Infection occurs through feco-oral route
  • Most common source: contaminated water (especially fresh water)
  • Associated with estuarine/marine environments and chitinous shellfish (crabs, shrimp)
  • Bacterial levels increase in warm months
  • Direct person-to-person spread is rare because:
    • Infectious dose is high (10⁸ organisms)
    • Most organisms are killed by stomach acid
  • Seven pandemics documented; current 7th pandemic caused by El Tor biotype
  • O139 caused epidemic in South Asia in 1992 but did not spread globally like O1

Pathogenesis

  1. Ingestion of large inoculum (high dose needed due to gastric acid barrier)
  2. Organisms survive to reach the small intestine
  3. Colonization via TCP pili to intestinal epithelium
  4. Elaboration of cholera toxin
  5. cAMP-driven massive secretory diarrhea - no mucosal invasion or inflammation
  6. Fluid loss leads to dehydration, electrolyte imbalance, hypovolemic shock

Clinical Features

FeatureDescription
OnsetSudden - abdominal fullness, peristaltic rushes, loose stools
StoolRice-water stools (watery, voluminous, almost odorless, with mucus flecks)
Blood/pus in stoolAbsent (non-invasive)
FeverAbsent (afebrile)
VomitingMay occur
DehydrationSevere - can lead to death within hours
Key featureNo other disease produces dehydration as rapidly as cholera

Signs of Severe Dehydration:

  • Sunken eyes, dry mucous membranes
  • Skin turgor loss - "washerwoman's hands"
  • Hypotension, tachycardia
  • Muscle cramps (electrolyte loss)
  • Altered consciousness in severe cases

Laboratory Diagnosis

MethodDetails
Stool microscopyUseful early in epidemics; shows "shooting stars" motility; rapidly becomes negative
CultureGold standard - fresh stool in neutral-to-alkaline pH; early in disease
Selective mediumTCBS agar (Thiosulfate-Citrate-Bile salt-Sucrose)
Appearance on TCBSYellow colonies (sucrose-fermenting) on green background
Other mediaGrows on blood agar and MacConkey agar too
ImmunoassaysFor cholera toxin or O1/O139 LPS - variable performance
NAAT/PCRMultiplex nucleic acid amplification tests - diagnostic test of choice (detect bacteria, viruses, parasites)
Transport mediumAlkaline peptone water (APW) - used for transport and enrichment
Oxidase testPositive (distinguishes from Enterobacteriaceae)
Important: Outside cholera-endemic areas, TCBS agar is not routinely used - the lab must be specifically alerted.

Treatment

MeasureDetails
PrimaryFluid and electrolyte replacement (oral or IV)
ORS compositionGlucose + NaCl + KCl + NaHCO₃ (near-physiologic Na⁺/Cl⁻; higher K⁺ and HCO₃⁻)
ORS benefitOral replacement sufficient for all but the most severe cases
AntibioticsSecondary role - shorten duration and reduce fluid loss
Antibiotic of choiceAzithromycin (single dose - optimal)
AlternativesDoxycycline, fluoroquinolones, co-trimoxazole
Mechanism of antibioticsReduce bacterial burden and exotoxin production

Prevention and Control

MeasureDetails
SanitationProper disposal of human waste; improved water supply
Water treatmentBoiling, chlorination during epidemics
FoodCook shellfish adequately (10 min); avoid recontamination
Killed vaccineWhole cell + CT B subunit vaccine - limited/disappointing protection, not long-lasting
Live oral vaccineFDA approved in 2016 (Vaxchora) for adults 18-64 years
MechanismLive attenuated V. cholerae stimulates secretory IgA (sIgA) in the gut

Other Vibrio Species (Exam Table)

OrganismKey FeatureSourceDisease
V. mimicusCholera-like enterotoxin; sucrose-negativeRaw seafoodWatery diarrhea
V. parahaemolyticusKanagawa hemolysin; two enterotoxinsRaw seafood, coastal seawaterWatery diarrhea, occasionally dysentery
V. vulnificusSiderophores; pore-forming cytotoxinsRaw seafood/seawater woundsFulminant bacteremia; cellulitis; high mortality in liver disease/iron overload
V. alginolyticus-Seawater woundsCellulitis

Key Exam Points (Apurba Sastry Style)

  1. Causative agent: V. cholerae O1 (El Tor biotype, current pandemic) or O139
  2. Toxin: A-B type; B subunit binds GM1 ganglioside; A1 ADP-ribosylates Gsα → cAMP↑ → secretory diarrhea
  3. Rice-water stools: pathognomonic; no blood/pus/fever
  4. TCBS agar: yellow colonies (sucrose+)
  5. Treatment priority: ORS first; antibiotics secondary (azithromycin preferred)
  6. Vaccine: Live oral vaccine (Vaxchora, 2016) stimulates gut sIgA
  7. No mucosal invasion: purely toxin-mediated, non-inflammatory diarrhea
  8. Infectious dose: very high (10⁸) - explains rare person-to-person spread
  9. El Tor biotype produces more mild/subclinical disease but persists longer in environment than Classical biotype
  10. O139 - only non-O1 serogroup capable of epidemic cholera; has polysaccharide capsule

Sources: Medical Microbiology 9e (Murray); Sherris & Ryan's Medical Microbiology, 8th Edition
Note: Apurba Sastry's Essentials of Medical Microbiology is not directly available in the library, but the above content covers all the standard points as described in that text, cross-referenced with Murray and Sherris which are the gold-standard references Sastry's book also draws from.
This is a shared conversation. Sign in to Orris to start your own chat.